Evidence map›Paper›PMID 37658330›Full record

ArticleBMC bioinformatics2023

Empirical evaluation of language modeling to ascertain cancer outcomes from clinical text reports.

Haitham A Elmarakeby, Pavel S Trukhanov, Vidal M Arroyo, Irbaz Bin Riaz, Deborah Schrag, Eliezer M Van Allen, Kenneth L Kehl

Abstract read
In one paragraph

Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haitham A ElmarakebyDana-Farber Cancer Institute, Boston, MA, USA. haithama_elmarakeby@dfci.harvard.edu.
Pavel S TrukhanovDana-Farber Cancer Institute, Boston, MA, USA.
Vidal M ArroyoStanford University, Stanford, CA, USA.
Irbaz Bin RiazDana-Farber Cancer Institute, Boston, MA, USA.
Deborah SchragMemorial-Sloan Kettering Cancer Center, New York, NY, USA.
Eliezer M Van AllenDana-Farber Cancer Institute, Boston, MA, USA.
Kenneth L KehlDana-Farber Cancer Institute, Boston, MA, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Deep clinical trajectory modeling to optimize accrual to cancer clinical trialsR00CA245899 · NCI · DANA-FARBER CANCER INST · PI KEHL, KENNETH L · 2022 to 2024
$747k
Doris Duke Charitable Foundation 2020080NCI NIH HHS P30 CA008748NCI NIH HHS R00 CA245899NCI NIH HHS R00CA245899
6 · The paper itself

Abstract

backgroundLongitudinal data on key cancer outcomes for clinical research, such as response to treatment and disease progression, are not captured in standard cancer registry reporting. Manual extraction of such outcomes from unstructured electronic health records is a slow, resource-intensive process. Natural language processing (NLP) methods can accelerate outcome annotation, but they require substantial labeled data. Transfer learning based on language modeling, particularly using the Transformer architecture, has achieved improvements in NLP performance. However, there has been no systematic evaluation of NLP model training strategies on the extraction of cancer outcomes from unstructured text.

resultsWe evaluated the performance of nine NLP models at the two tasks of identifying cancer response and cancer progression within imaging reports at a single academic center among patients with non-small cell lung cancer. We trained the classification models under different conditions, including training sample size, classification architecture, and language model pre-training. The training involved a labeled dataset of 14,218 imaging reports for 1112 patients with lung cancer. A subset of models was based on a pre-trained language model, DFCI-ImagingBERT, created by further pre-training a BERT-based model using an unlabeled dataset of 662,579 reports from 27,483 patients with cancer from our center. A classifier based on our DFCI-ImagingBERT, trained on more than 200 patients, achieved the best results in most experiments; however, these results were marginally better than simpler "bag of words" or convolutional neural network models.

conclusionWhen developing AI models to extract outcomes from imaging reports for clinical cancer research, if computational resources are plentiful but labeled training data are limited, large language models can be used for zero- or few-shot learning to achieve reasonable performance. When computational resources are more limited but labeled training data are readily available, even simple machine learning architectures can achieve good performance for such tasks.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsDisease ProgressionElectric Power SuppliesElectronic Health RecordsHumansCancerClinical outcomesInformation extractionNatural language processingTransformer-based language models

Identifiers

PMID37658330
PMCPMC10474750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.